- The Crohn’s disease market is experiencing steady growth due to advancements in treatment options and increasing patient awareness, leading to better diagnosis and management of the condition
- Innovations in biologic therapies and personalized medicine are enhancing patient outcomes, making the market more dynamic and expanding the range of available treatment solutions
- North America leads the Crohn’s disease market with the largest revenue share in 2024, driven by advanced healthcare infrastructure, rising disease awareness, and widespread adoption of innovative diagnostic and therapeutic options
- Asia-Pacific region is expected to witness the highest growth rate in the global crohn’s disease market, driven by increasing awareness, improving healthcare infrastructure, and growing adoption of advanced diagnostic and treatment options across countries such as China, Japan, and India
- Colonoscopy segment dominates the largest market revenue share in 2024, driven by its critical role in direct visualization and biopsy of the gastrointestinal tract. It remains the gold standard for diagnosis and monitoring of Crohn’s disease, favoured by healthcare providers for its comprehensive assessment capabilities
